 | Immunic's (IMUX) "Buy" Rating Reiterated at Wedbush americanbankingnews.com - April 17 at 3:12 PM |
 | Immunic, Inc. (NASDAQ:IMUX) Short Interest Update americanbankingnews.com - April 17 at 9:12 AM |
 | Brokerages Anticipate Immunic, Inc. (NASDAQ:IMUX) Will Post Earnings of -$0.69 Per Share americanbankingnews.com - April 15 at 2:20 PM |
 | Immunic (NASDAQ:IMUX) Earns Buy Rating from Analysts at Aegis americanbankingnews.com - April 15 at 11:56 AM |
 | Immunic, Inc. Announces EMPhASIS Interim Analysis of 10 mg Cohort Confirms IMU-838's Dose Response in Relapsing-Remitting Multiple Sclerosis and Supports Phase 3 Dose Selection finance.yahoo.com - April 15 at 10:05 AM |
 | Health Care Sector Update for 03/31/2021: IMUX,SURF,CASI,NMTR - Nasdaq nasdaq.com - March 31 at 8:46 PM |
 | Immunic and 4SC AG Sign Agreement Regarding the Settlement of Royalty Obligations for Immunic's Lead Program, IMU-838 markets.businessinsider.com - March 31 at 8:55 AM |
 | Immunic, Inc. (NASDAQ:IMUX) Given Average Recommendation of "Buy" by Brokerages americanbankingnews.com - March 31 at 5:00 AM |
 | A myriad of drugs are in the pipeline for Ulcerative Colitis treatment: DelveInsight - GlobeNewswire globenewswire.com - March 31 at 12:58 AM |
 | Immunic (NASDAQ:IMUX) Earns Market Outperform Rating from Analysts at JMP Securities americanbankingnews.com - March 30 at 8:32 AM |
|
 | Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect - Yahoo Finance finance.yahoo.com - March 24 at 11:17 PM |
 | Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect finance.yahoo.com - March 24 at 6:16 PM |
 | Immunic has a potentially good multiple sclerosis candidate: JMP - Seeking Alpha seekingalpha.com - March 24 at 1:15 PM |
 | Immunic Gets Bullish Rating On Multiple Sclerosis Drug Prospect - Benzinga benzinga.com - March 24 at 1:15 PM |
 | Should You Take Comfort From Insider Transactions At Immunic, Inc. (NASDAQ:IMUX)? finance.yahoo.com - March 19 at 1:08 PM |
 | Form 10-K IMMUNIC, INC. For: Dec 31 - StreetInsider.com streetinsider.com - February 26 at 1:04 PM |
 | Form 8-K IMMUNIC, INC. For: Feb 26 - StreetInsider.com streetinsider.com - February 26 at 1:04 PM |
 | Immunic's IMU-838 Shows Promising Clinical Effect In Mid-Stage Liver Disease Study - Yahoo Finance finance.yahoo.com - February 19 at 2:50 PM |
 | Form 8-K IMMUNIC, INC. For: Feb 17 - StreetInsider.com streetinsider.com - February 19 at 9:49 AM |
 | Immunic’s oral immune therapy shows positive effect rare liver disease trial - Seeking Alpha seekingalpha.com - February 18 at 11:21 PM |
 | Immunic's IMU-838 Shows Promising Clinical Effect In Mid-Stage Liver Disease Study finance.yahoo.com - February 18 at 1:20 PM |
 | Immunic, Inc. Announces That Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial - Yahoo Finance finance.yahoo.com - February 17 at 7:32 PM |
 | Immunic (IMUX) Announces Oral Treatment IMU-838 Shows Evidence of Clinical Activity in Moderate COVID-19 in Phase 2 CALVID-1 Trial - StreetInsider.com streetinsider.com - February 17 at 2:31 PM |
 | Immunic's IMU-838 shows evidence of clinical activity in COVID-19 - Seeking Alpha seekingalpha.com - February 17 at 2:31 PM |
 | IMU-838 Data In COVID-19 Study Fails To Cheer Immunic Investors; Stock Tanks - Benzinga benzinga.com - February 17 at 2:31 PM |
 | Immunic's IMU-838 Shows Evidence Of Clinical Activity In Moderate COVID-19 In Phase2 Trial - Nasdaq nasdaq.com - February 17 at 2:31 PM |
 | IMU-838 Data In COVID-19 Study Fails To Cheer Immunic Investors; Stock Tanks finance.yahoo.com - February 17 at 2:30 PM |
 | Immunic, Inc. to Participate in the SVB Leerink 10th Annual Global Healthcare Conference on February 25 - Yahoo Finance finance.yahoo.com - February 11 at 7:13 AM |
|
 | Immunic, Inc. to Participate in the SVB Leerink 10th Annual Global Healthcare Conference on February 25 finance.yahoo.com - February 11 at 7:13 AM |
 | Immunic: Competitive Phase 2 Data In Multiple Sclerosis - Seeking Alpha seekingalpha.com - January 24 at 10:06 AM |
 | Immunic, Inc. to Participate in Investor Conferences in January finance.yahoo.com - January 5 at 8:50 AM |
 | IDEAYA Biosciences, I-Mab & Immunic will be added to NASDAQ Biotechnology Index - Seeking Alpha seekingalpha.com - December 14 at 6:31 PM |
 | Immunic, Inc. to Participate in Investor Conferences in December finance.yahoo.com - November 24 at 9:32 AM |
 | Immunic, Inc. Announces Formation of Scientific-Medical Advisory Board finance.yahoo.com - November 17 at 6:53 AM |
 | Form S-3 IMMUNIC, INC. - StreetInsider.com streetinsider.com - November 13 at 10:37 PM |
 | Immunic, Inc. to Participate in Investor and Scientific Conferences in November finance.yahoo.com - November 10 at 8:04 AM |
 | Form 10-Q IMMUNIC, INC. For: Sep 30 - StreetInsider.com streetinsider.com - November 6 at 2:58 PM |
 | Immunic: 3Q Earnings Snapshot - Yahoo Finance finance.yahoo.com - November 6 at 2:58 PM |
 | Immunic, Inc. Reports Third Quarter 2020 Financial Results and Provides Corporate Update finance.yahoo.com - November 5 at 7:27 PM |
 | Enrollment underway in Immunic's Phase 2 part of IMU-838 study in COVID-19 seekingalpha.com - November 2 at 8:49 AM |
 | Immunic Enrolls 200 Patients In Phase 2 CALVID-1 Trial Of IMU-838 - Quick Facts nasdaq.com - November 2 at 8:49 AM |
 | Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed finance.yahoo.com - November 2 at 8:48 AM |
 | Coronavirus update: U.S. braces for third wave; Moderna manages vaccine expectations finance.yahoo.com - October 22 at 12:31 PM |
 | Immunic secures €24.5M in loan financing seekingalpha.com - October 22 at 7:30 AM |
 | EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy - Yahoo Finance finance.yahoo.com - October 21 at 1:14 AM |
 | EIB Provides Immunic With Up To €24.5M To Support Ongoing Development Of A Potential COVID-19 Therapy - Benzinga benzinga.com - October 20 at 8:13 PM |
 | EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy finance.yahoo.com - October 20 at 10:12 AM |
 | Why Immunic's Stock Is Trading Higher Today - Yahoo Finance finance.yahoo.com - October 2 at 5:42 PM |
 | Cue Biopharma Welcomes Tamar Howson to its Board of Directors - StreetInsider.com streetinsider.com - September 17 at 10:52 PM |
 | Immunic, Inc. Publishes Full Unblinded Clinical Data From Phase 2 EMPhASIS Trial of IMU-838 in Patients With Relapsing-Remitting Multiple Sclerosis and Announces Poster Presentation at the MSVirtual2020 finance.yahoo.com - September 11 at 9:12 AM |